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Heme is an essential co-factor for many critical cellular processes.  The protozoan 
parasite Leishmania amazonensis is a heme auxotroph and must acquire heme from 
the environment.  One pathway of heme acquisition is through Leishmania Heme 
Response 1 (LHR1), a heme transporter localized to the plasma membrane and acidic 
intracellular compartments.  In this work we further characterize LHR1 and the 
mechanism by which it promotes heme uptake.  We show that overexpression of 
LHR1 in L. amazonensis increases the total parasite intracellular heme pool, and that 
expression in S. cerevisiae promotes uptake of the heme analog Zinc Mesoporphyrin 
IX (ZnMP).  Our results indicate that heme binding to LHR1 is pH independent, 
whereas heme transport by the parasites is more efficient under acidic conditions.  To 
examine the molecular mechanisms responsible for LHR1 heme transport, we 
performed a mutagenesis analysis of LHR1.  We show that three key tyrosines 
residues, Tyr-18, Tyr-80, and Tyr-129, located in predicted transmembrane domains 
near the cytoplasmic leaflet of the plasma membrane, are important for heme 
transport.  Although the mutant proteins appear to not affect promastigote growth, 
  
they have a profound inhibitory effect on intracellular amastigote replication in 
macrophages, and are necessary for virulence in vivo.  Finally, we also examine the 
differential regulation of LHR1 expression in a visceralizing species, L. chagasi, 
compared to L. amazonensis, a species that causes cutaneous lesions.  L. chagasi has 
higher amounts of LHR1 transcripts than L. amazonensis under heme-depleted 
conditions, and uptakes ZnMP faster and to a greater extent than L. amazonensis.  
This differential regulation of LHR1 may be due to differences in the gene 3ʹ 
Untranslated Regions (UTRs) between the two species.  This works adds to our 
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Chapter 1: An Introduction to Leishmania, Leishmaniasis, Heme, Iron, 
and Heme Transporters 
 The goal of this dissertation is to characterize the protozoan heme transporter, 
Leishmania Heme Response 1 (LHR1), and examine the potential role of differential 
heme acquisition and LHR1 regulation in two species of Leishmania.  In this chapter the 
necessary background information will be given.  First, an overview of the protozoan 
parasite Leishmania and the disease it causes, leishmaniasis, will be given.  Then the role 
of iron and heme in the parasite biology and leishmaniasis will be outlined, followed by a 
brief overview of the known heme transporters.  Finally, the current understanding of 
heme transport in Leishmania will be discussed. 
Leishmania 
 Leishmania parasites were first described in the late 1800s in skin lesions, called 
Delhi Sores, by Peter F. Borovsky, David Cunningham, and James Homer Wright (3-5).  
A few years later in the early 1900s, William Leishman and Charles Donovan 
independently described Leishmania parasites in the spleens of patients with kala azar (6-
8).  Leishmania spp. are protozoan parasites that belong to the Trypanosomatidae family 
that have a bimodal life cycle alternating between a sand fly vector and a vertebrate host.  
When a sand fly ingests a blood meal containing amastigote forms of Leishmania, the 
parasites transform into extracellular procyclic promastigotes and replicate within the 
digestive tract of the sand fly.  After a few days, the procyclic promastigotes differentiate 
into infective metacyclic promastigotes and migrate to the proboscis of the sand fly.  




into the skin of another vertebrate host.  The metacyclic promastigotes are phagocytosed 
by macrophages, where they transform into the intracellular amastigotes and replicate 
inside a parasitophorous vacuole (PV) that shares many properties of phagolysosomes 
(9).  The cycle is completed when another sand fly takes a blood meal from an infected 
host that contains amastigote forms (Figure 1). 
 
        
Figure 1 – Life Cycle of Leishmania.  Illustration depicting the different life cycle stages of L. 
amazonensis from Kaye & Scott 2011 (1).  Below the life cycle are scanning electron micrographs of an 
amastigote and a promastigote form.  Images  courtesy of A. Flannery, B. Mittra and the Laboratory for 





Leishmania spp. cause a spectrum of human disease called leishmaniasis.  The 
clinical manifestations of leishmaniasis vary, and depending upon the infecting species 
and the host, range from self-healing cutaneous lesions to severely disfiguring 
mucocutaneous disease, or serious visceralizing disease that can be fatal if not treated.  
There are more than twenty known species of Leishmania that can cause disease in 
vertebrate animals, with approximately a dozen species known to infect humans.  The 
World Health Organization estimates that leishmaniasis is the ninth largest disease 
burden attributed to an individual infectious disease and the second largest human 
parasitic infection after malaria (10).  Approximately 310 million people living in 
countries where 90% of reported leishmaniasis cases occur are at risk for infection, and 
there are approximately 1.3 million new cases occurring annually with more than 20,000 
deaths (11).  Leishmania transmission is currently endemic in more than eighty tropical 
and subtropical countries.  In 2012, India, Brazil, South Sudan, Sudan, and Ethiopia 
reported the greatest number of visceral leishmaniasis cases, and Afghanistan, Syria, 
Brazil, and Iran reported the greatest number of cutaneous leishmaniasis cases (12) 
(Figure 2).  Current treatments are expensive and quite toxic, and drug resistance has 
arisen in highly endemic areas (13-15). Consequently there is a great need for 





     
Figure 2 – Global Distribution of Leishmaniasis 2012.  The World Health Organization (WHO) 





Iron and Heme at the Host-Parasite Interface 
 In leishmaniasis the availability of nutrients for parasite growth is known to have 
a drastic effect on disease outcome (16).  Two of those key nutrients are iron (Fe) and 
heme.  Iron is an essential element for many biological processes because its oxidation-
reduction (redox) potential can facilitate multiple types of electron transfer reactions.  In 
biological systems iron normally exists in either of two oxidation states, Fe2+ or Fe3+.  
This inherent characteristic of iron to undergo redox reactions also makes it toxic because 
it can serve as a catalyst in generating reactive oxygen species via the Fenton reaction 
(17).  During an infection, both the host and the parasite require iron to perform normal 
biological functions, but in addition, the host must limit a pathogen’s access to iron in 
order to prevent pathogen replication (18).  This battle for iron within the host is 
illustrated well by the divalent cation transporter Natural Resistance-Associated 
Macrophage Protein 1 (NRAMP1), also called Solute Carrier (Slc11a1), which is 
specifically expressed in professional phagocytes such as macrophages.  NRAMP1 
removes iron and other divalent cations from late endocytic compartments, consequently 
depriving intracellular pathogens like Leishmania of these important factors.  NRAMP1 
was identified as a host susceptibility gene for Leishmania infection; thus providing the 
first evidence that Leishmania is acutely dependent on the availability of iron for 
intracellular growth and replication (19,20).  NRAMP1 normally resides in the late 
endosome/lysosome of resting macrophages and is recruited to mature phagosomes (21).  
Leishmania is an intracellular parasite of macrophages, and its mechanisms to gain access 
to iron have been shown to influence the host cell’s ability to regulate iron pools by 




Heme also plays a central role in iron availability at the host-parasite interface via 
recycling of iron during erythrophagocytosis.  Erythrophagocytosis occurs in 
reticuloendothelial macrophages located mainly in the spleen and to a lesser extent in the 
liver and bone marrow (24).  In humans, approximately 5 million red blood cells are 
recycled each second via erythrophagocytosis, which provides twenty-fold more iron 
than absorption from the diet (25-27).  Senescent red blood cells are phagocytosed by 
macrophages and degraded in phagolysosomes releasing heme.  Heme is then 
translocated to the cytosol via Heme Response Gene 1 (HRG1) (25) where it is degraded 
via heme oxygenase (HO-1) to release iron from the porphyrin ring.  Iron is then 
available to be stored in ferritin in the cytosol of the macrophage or it can be transported 
out of the cell via ferroportin (Figure 3).  At a critical junction in this iron and heme 
recycling pathway sits Leishmania, which replicates inside PVs, phagosomal-like 
compartments that are found in macrophages.  L. amazonensis has been shown to posses 
a ferric iron reductase (LFR1) and a ferrous iron transporter (LIT1) that work in concert 
to allow the parasite to reduce extracellular ferric iron (Fe3+) to ferrous iron (Fe2+) and 
then transport that ferrous iron across the plasma membrane (28-31) (Figure 3).  In 
addition to the ability to acquire iron directly from the environment, Leishmania can also 






 Heme is an iron-containing porphyrin that acts as an important prosthetic group 
for many enzymes involved in a variety of cellular functions (Figure 4) (36).  The heme 
biosynthesis pathway in eukaryotes consists of eight enzymes located in the cytoplasm 
and in the mitochondria and has been well characterized (37).  However, not all 
eukaryotes have the ability to synthesize heme, generally because they are lacking one or 
more of the enzymes in the biosynthetic pathway.  Heme is a large amphipathic 
 
Figure 3 – Macrophages Recycle Iron via Erythrophagocytosis.  Hemoglobin is degraded in the 
phagolysosome releasing heme, which is translocated into the cytosol by HRG1 where it can be broken 
down by HO-1.  This iron can be exported by ferroportin or stored in ferritin.  Within the PV, L. 




porphyrin that is toxic in its free form because of its ability to intercalate into lipid 
membranes and catalyze the formation of reactive oxygen species (ROS) causing 
oxidative stress that can damage proteins, lipid membranes, and nucleic acids (38,39).  
Consequently, in biological systems, heme is usually maintained in a protein-bound form 
to protect the cell from its toxic effects (40).  In order to supply heme to the 
compartments where it is needed as a cofactor in hemoproteins and maintain iron 
homeostasis, cells use heme importers and exporters to facilitate movement of heme 
within the cell. 
Leishmania are heme auxotrophs that lack the first five enzymes in the heme 
biosynthetic pathway but possess the final three, which have been annotated in the 
genome and shown to be enzymatically active (32,41-52).  L. amazonensis has been 
shown to bind heme specifically (53), and L. donovani was shown to have a transporter, 
Leishmania ATP-Binding Cassette G5 (LABCG5), proposed to be involved in salvage of 
heme after breakdown of hemoglobin.  LABCG5 was proposed to function in a 
mechanistically different manner, when compared to direct heme uptake (54).  Heme 
plays an essential role in the replication and survival of Leishmania, and a better 






The existence of human heme transporters was first observed in intestinal and 
hepatocyte cells lines (55), but only a few proteins have been fully characterized as 
dedicated heme transporters (38,39,56).  Two classes of heme transporters, heme 
importers and heme exporters, are described below using the heme tranport proteins that 
have been characterized. 
Heme Importers 
Heme Carrier Protein 1 (HCP1) (also known as Solute Carrier Family 46A1 
(SLC46A1) / Proton Coupled Folate Transporter (PCFT)), which is located on the plasma 
 
Figure 4 – Heme Biosynthesis Pathway.  Leishmania only possesses the last three enzymes of the 




membrane in mammalian cells, was initially thought to import heme (57).  However, 
HCP1 was later shown to be primarily a folate transporter with lower affinity for heme 
(58-60).  The best characterized heme importers, Heme-Responsive Gene 1 (CeHRG-1) 
and Heme-Responsive Gene 4 (CeHRG-4) were discovered using a genetic screen in the 
heme auxotrophic organism C. elegans (61).  CeHRG-1 localizes to endosomes and 
lysosomes, binds heme better at low pH values, and utilizes a histidine in the predicted 
transmembrane domain 2 as well as the C-terminal FARKY motif (a potential heme 
interacting cluster of basic and aromatic amino acids) to transport heme.  CeHRG-4 
localizes to the plasma membrane, binds heme over a broad pH range, and utilizes a 
histidine in extracellular loop 2 as well as the FARKY motif to transport heme (61,62).  
Of all the heme responsive genes identified in the C. elegans genetic screen, only 
CeHRG-1 has a human homologue, hHRG-1 (also known as Solute Carrier Protein 48A1 
(SLC48A1), which has been shown to localize to the plasma membrane and endosomal 
membranes, transports heme from the endosome into the cytoplasm, and is involved in 
heme salvage during erythrophagocytosis (25,61-65).  Feline Leukemia Virus Subgroup 
C Receptor 2 (FLVCR2) is a heme importer located on the plasma membrane in 
mammalian cells that is associated with a vascular disease of the brain, Fowler 
Syndrome. However, there is mixed evidence about the ability of this protein to import 
heme (38,62,66-68) 
Heme Exporters 
Feline Leukemia Virus Subgroup C Receptor 1a (FLVCR1a) is a heme exporter 
located at the plasma membrane in mammalian cells that is required for erythroid 




posterior column ataxia and retinitis pigmentosa syndrome and Blackfan anemia 
(38,67,69,70).  Feline Leukemia Virus Subgroup C Receptor 1b (FLVCR1b), another 
isoform of FLVCR1a, is a mitochondrial heme exporter that is involved in erythroid 
differentiation (71).  The ATP-binding cassette G2/breast cancer resistance protein 
(ABCG2/BCRP) is a heme exporter located on the plasma membrane that is involved in 
hypoxic cell survival (72) and transfers heme to albumin via an extracellular loop (73), 
and may be involved in porphyrin homeostasis.  ATP-Binding cassette B6 (ABCB6) may 
play a role in heme transport, but there is mixed evidence as to its physiological role (74-
81). 
Leishmania Heme Transporters 
This characterization of heme transporters in animals has facilitated the 
identification of heme transporters in Leishmania (31,82,83).  The first heme transporter 
characterized was LABCG5 in L. donovani.  LABCG5 is a putative heme importer 
located in the flagellar pocket and on internal vesicles of the parasites proposed to 
mediate intracellular trafficking of heme to the mitochondria after breakdown of 
hemoglobin (54).  The second heme transporter characterized was LHR1 in L. 
amazonensis.  LHR1 localizes to the plasma membrane and acidic intracellular 
compartments, functions in the direct transport of heme from the environment into the 
cytoplasm (35), and was shown to be essential for virulence during macrophage and 




Heme Transport in Leishmania 
A few studies have been performed involving heme and Leishmania that provided 
guidance for our examinations of heme acquisition in L. amazonensis.  Galbraith et al. 
showed that heme binds specifically to the surface of L. amazonensis promastigotes with 
a Kd of ~ 0.03 nM-1 (53), and Carvalho et al. showed that L. infantum amastigotes have a 
ligand for heme on their surface with a Kd of ~ 0.044 nM-1 (34).  Campos-Salinas et al. 
used a fluorescent heme analog, Magnesium Protoporphyrin IX (MgPP) in L. donovani to 
show, for the first time, that heme and hemoglobin uptake follow different pathways with 
different kinetics, and that direct heme uptake is temperature dependent (54).  In order to 
verify that L. amazonensis behaves in a manner similar to what had been described in 
other species, we collaborated with Dr. Tamika Samuel and Dr. Iqbal Hamza at the 
University of Maryland to demonstrate kinetic [55Fe]-heme uptake in L. amazonensis 
promastigotes over 120 minutes.  We were able to confirm previous observations that 
were made using other Leishmania species and heme analogs.  L. amazonensis takes up 
[55Fe]-heme with a kinetic curve that is indicative of a transporter at the plasma 





                       
Figure 5 - [55Fe]-heme Uptake in L. amazonensis.  Mid-log promastigotes were grown in heme-depleted 
conditions O/N before uptake assay was performed.  CPM from 0° C for parallel time points was 
subtracted from the CPM obtained at 26° C incubation.  Assays were performed in triplicate and data is 
representative of two independent experiments.  Data represents the mean +/- SD of triplicates.  (T. 




Chapter 2: Leishmania Heme Response 1 (LHR1) is a Heme 
Transporter 
Partially adapted from Huynh et al. PLoS Pathog 2012 (35) 
Introduction 
 Leishmania are known to be heme auxotrophs (32,41,46) and consequently 
completely dependent upon heme acquisition from the environment.  Because of this 
unique dependence on exogenous heme, Leishmania have multiple pathways of heme 
acquisition.  It has been proposed that Leishmania can acquire heme via hemoglobin 
receptor-mediated endocytosis followed by heme salvage (54,85-89) and via direct 
transmembrane transport (34,35,53,54).  Direct transmembrane transport of heme has 
also been observed in Trypanosoma cruzi, another member of the Trypanosomatidae 
family (90,91).  LHR1 is a heme transporter that is involved in direct transmembrane 
heme transport that was discovered and characterized by the Andrews laboratory.  During 
the course of characterizing LHR1 we were able to show that LHR1 is a small 20 kDa 
protein, with four predicted transmembrane domains, that localizes to acidic intracellular 
compartments and the plasma membrane of promastigotes and amastigote stages of the 
parasite.  Importantly, LHR1 transcript levels increase when the parasites are grown 
under heme depleted conditions, a property that is expected of heme transporters.  LHR1 
is involved in the control of intracellular heme pools, can rescue the growth of a yeast 
strain defective in heme biosynthesis, and can directly transport radioactive heme when 





LHR1 Increases Total Intracellular Heme Concentrations 
 In order to verify that LHR1 was contributing to the total intracellular heme pools, 
two different tagged versions of LHR1 were created and episomally expressed in L. 
amazonensis.  The expression of either GFP-LHR1 or LHR1-3xFLAG increased the 
overall intracellular heme content (Figure 6).  The modulation of total intracellular heme 
pools upon over expression of the tagged constructs was moderate, but because of the 
inherent toxicity of heme, it is conceivable that intracellular concentrations would be 





Zinc Mesoporphyrin (ZnMP) Uptake Assays in the Yeast Saccharomyces cerevisiae 
 To characterize LHR1 as a heme transporter, we sought a kinetic assay that would 
reflect direct uptake of heme or a heme analog.  In order to do this, we took advantage of 
the S. cerevisiae yeast strain Δhem1 (6D) (62,92,93) because it utilizes exogenous heme 
poorly and is deficient in the biosynthetic pathway of heme.  Δhem1 (6D) cells 
expressing LHR1 were incubated with the fluorescent heme analog ZnMP at 30°C over 
90 minutes.  There was clear uptake of ZnMP in cells expressing LHR1 when compared 
               
Figure 6 – Overexpression of GFP-LHR1 and LHR1-3xFLAG Increases the Intracellular Heme 
Content in L. amazonensis.  Promastigotes overexpressing two different tagged version of LHR1 both 
showed an increase in intracellular heme content.  A) Representative absorption spectra of hemochrome 
content of L. amazonensis promastigote lysates (4x109 parasites) transfected with vectors only (GFP 
and 3xFLAG) or LHR1 (GFP-LHR1 and LHR1-3xFLAG) grown in regular growth media.  B) 
Calculated heme concentrations from (A) based on heme millimolar extinction coefficient of 20.7.  
Data represented is the mean ± standard error of three independent experiments.  * p = 0.020 (GFP-




to cells with empty vector, and this uptake could be significantly reduced when incubated 
with 10-fold excess hemin indicating hemin can compete with ZnMP for uptake via 
LHR1 (Figure 7). 
 
Efforts to Generate L. amazonensis Δlhr1/Δlhr1 
 We were able to generate a heterozygous knockout of LHR1 in L. amazonensis 
(Δlhr1/LHR1; referred to as SKO) via homologous recombination using a hygromycin B 
phosphotransferase (HYG) replacement construct where the HYG gene was flanked on 
 
Figure 7 – LHR1 Promotes ZnMP Uptake in Yeast Δhem1 (6D).  Yeast transformed with LHR1-HA 
or empty vector were incubated with 100 µM ZnMP or 100 µM ZnMP + 1000 µM hemin at 30°C for 
varying lengths of time.  Fluorescence was measured using FACS.  Error bars are the standard deviation 




the 3ʹ end with 1000-bp region upstream of LHR1 and on the 5ʹ end with a 2,500-bp 




generate a homozygous knockout of LHR1 using the neomycin phosphotransferase 
(NEO) gene deletion construct described in Figure 8, we were unable to recover viable 
parasites.  Ultimately we attempted to replace the second endogenous copy of LHR1 by 
first episomally expressing LHR1-3xFLAG in the SKO and then using the NEO gene 
replacement construct to replace the final copy.  Triple drug resistant parasites were 
recovered (hygromycin = first copy of LHR1; nourseothricin = episomal LHR1-3xFLAG; 
neomycin = second copy of LHR1) and genomic DNA was isolated and tested using a 
PCR assay to verify if the neomycin resistance gene had in fact replaced the second 
endogenous copy of LHR1.  The primers used for the PCR were designed specifically to 
detect 1) the HYG gene (Hyg) in the LHR1 genomic locus, 2) the episomally expressing 
LHR1-3xFLAG (Flag), 3) endogenous LHR1 (LHR1) and 4) NEO gene (Neo) gene in the 
 
Figure 8 – Illustration of Gene Replacement Constructs to Generate L. amazonensis Δlhr1/Δlhr1.  





LHR1 genetic locus.  Two independent genomic isolations from recovered isolates were 
run in PCR reactions with the multiple primer sets, and the band pattern indicated that 




Characterization of L. amazonensis Δlhr1/LHR1 (SKO) Using [55Fe]-heme Uptake 
 In collaboration with Dr. Tamika Samuel, we performed further characterization 
of the SKO parasites using [55Fe]-heme uptake assays in parasites grown under heme-
depleted and regular conditions.  As expected, mid-log promastigote forms of WT L. 
amazonensis and SKO showed increased heme uptake when grown in heme-depleted 
 
Figure 9 – Triple Drug Resistant Isolates Still Contain an Endogenous Copy of LHR1.  Genomic 
DNA from potential Δlhr1/Δlhr1 clones episomally expressing LHR1-3xFLAG that were resistant to 
hygromycin B (100 µg/ml), nourseothricin (50 µg/ml), and G418 (50 µg/ml) was subjected to PCR to 
detect the different copies of drug resistance cassettes or LHR1 that could be present.  Gel is 




conditions, with WT L. amazonensis showing a 8.5-fold increase and SKO a 2.5-fold 
increase over basal uptake (Figure 10).  Interestingly, in this assay the SKO showed a 
2.8-fold higher heme uptake under basal conditions when compared to WT L. 
amazonensis, and only slightly lower levels than WT under heme-depleted conditions.  
The difference in heme uptake between WT and SKO L. amazonensis when grown under 
heme-depleted conditions is not as large as what was observed previously when uptake 
was measured using ZnMP (35).  This disparity is potentially due to the differences in the 
time point at which uptake was measured.  The radioactive heme uptake assay measured 
uptake after 60 minutes, whereas ZnMP uptake was measured after 3 hours; it is possible 
that a larger difference between WT L. amazonensis and the SKO grown in heme-






LHR1 Heme Binding is pH Independent and Heme Transport is pH Dependent 
 In L. amazonensis, GFP-LHR1 localizes to acidic intracellular compartments that 
accumulate lysotracker and to the plasma membrane (35), and LHR1-3xFLAG localizes 
mostly to acidic intracellular compartments (D. Miguel, unpublished results).  These 
localization patterns raised the question as to whether LHR1-mediated heme transport 
across membranes occurs at the plasma membrane, or after endocytosis into the parasite’s 
endosomal/lysosomal pathway.  To investigate this we tested the binding affinity of 
LHR1 for heme over a range of pH values from 5-8.  We used LHR1-3xFLAG 
overexpressing L. amazonensis to generate cell lysates buffered at varying pH values to 
test the ability of LHR1 to bind heme over a range of pH values using hemin-agarose.  
                         
Figure 10 – WT L. amazonensis and SKO Show Increased Heme Uptake When Grown in Heme-
depleted Conditions.  Parasites were grown in heme-depleted or regular media O/N and [55Fe]-heme 
uptake was performed for 60 min.  CPM of 0° C was subtracted from CPM of 26° C and then 
normalized to mg protein.  Assay was performed in triplicate and data is representative of 2-3 





We found that LHR1 binding to hemin-agarose was independent of pH (Figure 11 A).  
To provide further evidence, we grew the Δhem1 (6D) yeast strain, which has a non-
functional heme biosynthesis pathway and utilizes exogenous heme poorly, transformed 
with vector alone, C. elegans HRG-4-HA, or L. amazonensis LHR1-HA in 1 µM hemin 
at pH 5 and 6 (this strain is unable to grow at pH 7 or 8) and observed no differential 
growth pattern (Figure 11 B), indicating that LHR1 is capable of rescuing heme uptake 
under these two different levels of acidity.  These findings are consistent with previous 
observations showing that C. elegans HRG-4, the heme transporter most closely related 






Working in collaboration with Dr. Tamika Samuel we performed radioactive 
heme binding and uptake assays at different pH values and temperatures as part of the 
optimization process to characterize kinetic heme uptake in L. amazonensis.  We 
 
Figure 11 – Heme Binding to LHR1 is Independent of pH.  A) LHR1-3xFLAG binding to hemin-
agarose at different pH values.  Input represents 20% of total input protein.  Bound is total protein 
eluted from beads.  4B is sepharose 4B beads alone as a control for nonspecific binding.  Western blot 
is representative of three independent experiments.  The table shows the % of total protein that was 
bound to hemin-agarose and was calculated using densitometry in ImageJ software from the western 
blot pictured and is representative of three experiments.  B) Growth Spot Assay of Δhem1 (6D) 
transformed with vector alone (vector), C. elegans HRG-4-HA (CeHRG-4) or L. amazonensis LHR1-





incubated L. amazonensis promastigotes with [55Fe]-heme at 0° C in pH 5.5 and pH 7.4 
buffer to assay heme binding, and at 26° C in pH 5.5 and pH 7.4 buffer to assay heme 
transport for 60 minutes, followed by quantitation of the [55Fe]-heme in lysates.  When 
parasites were incubated at 0° C for 60 min, there was no difference in [55Fe]-heme 
binding at the two pH values. In contrast, when the parasites were incubated at 26° C for 
60 min, the parasites in pH 5.4 appeared to take up more [55Fe]-heme than those at pH 7.4 
(Figure 12).  This suggests that binding of heme to LHR1 may be unaffected by pH but 
that transport might benefit from acidic conditions, consistent with the possibility that 
LHR1 translocates heme across the membrane into the cytosol from a parasite late 
endosomal/lysosomal compartment. 
 
                               
Figure 12 – [55Fe]-Heme Binding and Uptake in L. amazonensis.  L. amazonensis was incubated 
with [55Fe]-heme for 60 min at either 0° C or 26° C and [55Fe]-heme measured in cell lysates.  Assay 
was performed in triplicate and experiment was performed once.  Error bars represent standard 





 The dependence of Leishmania on exogenous heme was first characterized almost 
forty years ago (41), however it was not until recently that a protein, LHR1, responsible 
for direct heme acquisition in L. amazonensis was described (35).  LHR1 is only ~15% 
identical and ~45% similar to the bona fide heme transporter CeHRG-4 that has been 
characterized in C. elegans.  The studies done using CeHRG-4 provided a reference point 
for these Leishmania heme transport studies (35,61,62). 
In this work we showed that episomal expression of tagged versions of LHR1 
were able to modulate the total intracellular heme pool of L. amazonensis (Figure 6).  
Additionally, LHR1 expression in yeast was able to promote uptake of a fluorescent 
heme analog ZnMP that was not observed with vector alone and ZnMP uptake could be 
reduced when incubated with 10-fold excess hemin (Figure 7).  LHR1 null strains could 
not be generated despite all our efforts, suggesting that LHR1 is essential for survival of 
the promastigote forms.   
Using radioactive heme uptake, we further characterized L. amazonensis WT and 
SKO parasites grown in regular and heme-depleted conditions.  We expected that SKO 
parasites would have less [55Fe]-heme uptake than WT, but surprisingly under basal 
conditions the SKO parasites seem to import more or equal amounts of heme compared 
to WT cells.  Under heme-depleted conditions uptake is markedly increased, but there is 
no statistical difference between WT and SKO (Figure 10).  Given the genetic plasticity 
of Leishmania, (94) and since heme is essential for survival, it is not too surprising that 
the SKO parasites appear to have compensated for the lack of one LHR1 allele in order to 




Finally, we provide evidence that the binding of heme to LHR1 is independent of 
pH and some data suggesting that the LHR1-mediated transport of heme across the 
membrane is dependent upon pH (Figures 11 & 12).  It is entirely possible that binding of 
heme and the transport across the membrane are distinct in their pH dependencies.  One 
can envision a scenario for promastigotes, which replicate in the gut of the sand fly, 
where heme binds to LHR1 at the plasma membrane (where some transport could occur 
at neutral pH) and then the LHR1+heme complex is internalized and trafficked to acidic 
intracellular compartments of the parasite where heme is transported into the cytoplasm 
with greater efficiency. 
Campos-Salinas and co workers have looked at heme/heme analog acquisition in 
Leishmania using a visceralizing strain, L. donovani (54).  They showed that hemoglobin 
and free heme appear to follow different routes of entry, and that uptake of the heme 
analog MgPP followed faster kinetics than what we have described here for LHR1 from 
L. amazonensis.  The differences in the systems and heme analogs employed in the assays 
could account for the differences observed in kinetic acquisition (our assays were 
performed with ZnMP in yeast and theirs were performed with MgPP in L. donovani).  
There are only minor differences between the LHR1 proteins from L. amazonensis and L. 
donovani (93% identical, 98% similar) and these differences are not thought to play a 
role in the observed kinetic difference between our assays and the ones performed with L. 
donovani. 
 The findings presented here are significant because they further characterize 
LHR1 as a bona fide heme transporter, thereby adding to our understanding of heme 




(http://blast.ncbi.nlm.nih.gov) using LHR1 showed no significant homology to any 
known human proteins, which is supported by the fact that L. amazonensis LHR1 is most 
closely related to C. elegans HRG-4, which also does not have a human homologue (61).  
Consequently, small molecules designed to inhibit LHR1 may have less off target effects 
because there are no LHR1 homologues in humans.  LHR1 is essential for parasite 
survival within macrophages, providing additional evidence that LHR1 is an attractive 





Chapter 3: Differential Heme Acquisition in L. chagasi (L. infantum) 
and L. amazonensis 
Partially adapted from Flannery et al. Curr Opin Microbiol 2013 (31) 
Introduction 
 The markedly distinct clinical disease manifestations that occur after infection 
with different species of Leishmania are dependent upon the infecting species of 
Leishmania and the host (Figure 13).  The underlying mechanism(s) of the parasites that 
are responsible for these differences in clinical disease manifestations are not understood.  
Studies have been performed looking for species-specific genes that could potentially 
explain some trends in disease association, but so far there have been relatively few 
species-specific genes identified that could account for the varying disease manifestations 
(95-98).  Visceral leishmaniasis is characterized by parasite replication within 
macrophages of the spleen, liver, and bone marrow; whereas cutaneous leishmaniasis is 
characterized by replication within macrophages at the skin near the site of the initial 
sand fly bite (99).  Based on the location where infected macrophages reside in the two
 
Figure 13 – Table of Clinical Disease Manifestations and the Associated Leishmania species.  




forms of leishmaniasis, the heme availability at those sites has the potential to be quite 
different.  Macrophages in the spleen are involved in extensive phagocytosis of senescent 
red blood cells, a rich source of heme, whereas macrophages present in the skin are not 
likely to perform this role.  Given the potential differences in heme availability at the 
different sites where infected macrophages reside, it is possible that the acquisition of 
heme is differentially regulated between the two species, and examining this aspect could 
provide insights into the mechanism connecting disease outcome with the parasite 
species. 
 Regulation of gene expression in trypanosomatid parasites is not controlled by 
classical transcriptional promoters present in other eukaryotic cells (100).  Protein coding 
genes are arranged in polycistronic units with variable numbers of genes on the 
chromosomes (101-104), and RNA Polymerase II transcribes these arrays as 
polycistronic transcripts (105-108).  These polycistronic messages are subsequently 
processed via trans-splicing with a 39 nucleotide splice leader (SL) from the SL-RNA at 
the 5ʹ end and polyadenylation at the 3ʹ end to form mature monocistronic mRNAs (109-
112).  The 3ʹ polyadenylation of an upstream gene is coupled to SL 5ʹ trans-splicing of 
the downstream gene and the polyadenylation site of the upstream gene is selected based 
on the position of the downstream gene’s SL-acceptor site; consequently there is the 
potential for multiple polyadenylation sites and SL-acceptor sites within a given 
transcript (112,113).  There is little control over the initiation of transcription, and 
therefore trypanosomatids utilize extensive post-transcriptional regulation strategies such 
as mRNA stability, translation initiation, and post-translational protein modifications 




post-transcriptional gene regulation and there are many different mechanisms by which 
these elements could control gene expression (i.e. RNA binding protein sites, tertiary 
RNA structures, etc.) (116,117).  As part of the investigation into how trypanosomatids 
regulate gene expression, alternative splicing (100,118-121), mRNA stability (96,122-
133), differential translation (134-136), post-translational protein modifications (137-
141), and protein stability (142) have all been described as strategies employed to control 
gene expression. 
 Herein we investigate whether L. amazonensis and L. chagasi differ in their 
response to heme deprivation, their ability to acquire heme from the environment, and we 
focus on mechanism(s) of gene regulation that could be involved in regulating LHR1.  
This is significant because it could provide insight into the biological differences between 
cutaneous and visceral strains, which are poorly understood, and could influence future 
therapies and drug development.  We hypothesized that L. chagasi and L. amazonensis 
differ in their responses to heme deprivation and their ability to acquire heme from the 
environment by differentially regulating LHR1 mRNA. 
Results 
Higher LHR1 Transcript Levels in L. chagasi than L. amazonensis Under Heme Deplete 
Conditions 
 To ascertain potential differences in LHR1 regulation in L. chagasi and L. 
amazonensis, we used Reverse Transcription Quantitative Polymerase Chain Reaction 
(RT-qPCR) to examine transcript levels under different growth conditions.  It was 
already known that L. amazonensis has higher LHR1 transcript levels when grown in 




were grown in either regular or heme-depleted PGM for 24 h and RNA was isolated for 
use in RT-qPCR analysis.  L. chagasi had 11-fold higher and L. amazonensis had 4-fold 
higher amounts of LHR1 transcripts in heme-depleted conditions, compared to regular 
growth conditions (Figure 14). 
 
                 
Figure 14 – LHR1 Transcripts Levels are Higher in L. chagasi than L. amazonensis After Heme 
Deprivation.  L. amazonensis and L. chagasi were grown for 24 h in regular or heme-depleted media 
and RNA isolated for use in RT-qPCR.  Each sample was normalized to ubiquitin hydrolase transcript 
levels and regular media growth was considered 1.0.  Experiments were repeated three to five times.  
Errors shown are standard deviations.  Student’s t-test: L. chagasi Regular vs. Heme Deplete = 0.001; L. 
amazonensis Regular vs. Heme Deplete = 0.002; L. chagasi Heme Deplete vs. L. amazonensis Heme 




Differential Uptake of ZnMP by L. chagasi and L. amazonensis 
 Transcript levels do not always correlate well with proteins levels in 
trypanosomatids (132); consequently we examined if the differences in transcript levels 
observed under heme-depleted conditions reflected an increase in heme uptake, 
consistent with an increase in LHR1 protein levels.  To do this we used the fluorescent 
heme analog ZnMP that can be detected using a fluorescence microscope upon 
accumulation within parasites.  L. chagasi and L. amazonensis were incubated in heme-
depleted medium for 16 h, ZnMP was added, and uptake was quantified over time using 
fluorescence microscopy images and Volocity image analysis software (Improvision).  L. 
chagasi acquired detectable intracellular fluorescence earlier than L. amazonensis, and 
had higher mean fluorescence intensities per parasite at identical time points (Figure 15).  
This observation correlates directly with the higher transcript levels in L. chagasi upon 





Examination of the LHR1 Genomic Regions of L. chagasi and L. amazonensis 
 The extensive use of post-transcriptional regulation in trypanosomes led us to 
investigate the untranslated regions (UTRs) of LHR1 because of the role that UTRs have 
been shown to play in regulating gene expression via elements present in these regions of 
the mRNAs.  We examined the UTRs in each species in order to identify regions of 
interest that could potentially provide insight into our previously observed differential 
modulation of transcript levels and ZnMP uptake.  Using TriTrypDB 
 
Figure 15 – L. chagasi uptake ZnMP faster than L. amazonensis upon heme deprivation.  A) Mid-
log phase L. amazonensis and L. chagasi were grown for 16 h in heme-depleted medium.  10 µM ZnMP 
was added and cells were incubated at 26°C and imaged at 0, 1 and 3 h on a spinning disk confocal 
microscope using identical acquisition settings.  Scale bar is 9 µm.  B) Relative Mean Fluorescence per 
parasite was quantified at the 3 h time point using Volocity (PerkinElmer).  Graph is representative of 




(www.tritrypdb.org), we examined the LHR1 genomic regions for L. infantum 
(LinJ.24.2320) and L. mexicana (LmxM.24.2230), two closely related species to L. 
chagasi and L. amazonensis respectively.  We found that this region encompasses 
approximately 4,000 base pairs (distance from the end of the upstream gene to the start of 
the downstream gene) and that LHR1 is syntenic across a range of trypanosomatid 






The genomic regions (including the upstream gene, downstream gene, and 
intergenic regions) for L. mexicana and L. infantum were downloaded from TriTrypDB 





Figure 16 – LHR1 Genomic Region and Synteny Across a Range of Trypanosomatid Parasites.  
A) Table of LHR1 orthologs and paralogs within TriTryp DB.  B) Genome Browser from TriTrypDB 
showing the location of LHR1 on the L. mexicana genome and the synteny between species of the 
Trypanosomatidae family.  Lbra = L. braziliensis, Ldon = L. donovani, Linf = L. infantum, Lmaj = L. 
major, Ltar = L. tarentolae, Tbrg = T. brucei 927, Tb427 = T. brucei 427, Tb927 = T. brucei TREU927, 





identify any species-specific genomic sequences present.  The upstream and downstream 
genes were included in the alignment so that the intergenic regions would align in such a 
manner as to identify major differences between the two species.  Figure 17 is an 
illustration of the alignment showing that there was 87% identity between the two species 
with no major difference in the 5ʹUTRs or the ORFs, but with differences present in the 
3ʹUTRs.  L. mexicana is missing three sections of the 3ʹUTR that are present in L. 
infantum, gaps of 35, 39, and 44 bp. 
 
Identification of 3ʹ Polyadenylation Addition Sites in L. chagasi and L. amazonensis 
The LHR1 genomic region alignments revealed differences in the 3ʹUTR regions 
of these two genes, but it was unclear if these regions were within the mRNA for each 
species because the mRNA boundaries for LHR1 and its homologues in TriTrypDB were 
not annotated (only exception is the T. brucei TREU927 strain).  In order to confirm the 
sequence and define the 3ʹUTR boundaries for L. chagasi and L. amazonensis, mRNA 
from both species was isolated and used to amplify and sequence the LHR1 mRNA.  The 
 
Figure 17 - Illustration of Alignment of LHR1 Genomic Regions of L. infantum and L. mexicana.  
Genomic regions downloaded from TriTrypDB were aligned using Clustal Omega.  There was 87% 
identity between the two species, with three segments of the 3ʹUTR missing from L. mexicana that are 





LHR1 mRNA from the L. chagasi strain that we sequenced shared 99% identity with the 
L. infantum sequence from TriTrypDB, and the LHR1 mRNA from the L. amazonensis 
strain we sequenced shared 96% identity with the L. mexicana sequence from 
TriTrypDB.  LHR1 3ʹUTRs from L. chagasi and L. amazonensis were found to share 
83% identity and were 1.7 kb and 1.8 kb respectively (Figure 18).  The portions of the 
3ʹUTR (gaps of 35, 39, and 44 bp) found to be different in the genomic analysis, were 
absent from L. amazonensis 3ʹUTR but present in L. chagasi.  L. chagasi LHR1 mRNA 
utilizes two polyadenylation sites within a 10 nucleotide region and, L. amazonensis 
LHR1 utilizes three polyadenylation sites within a 30 nucleotide region.  When mRNAs 
were collected from these two species grown in heme-depleted conditions, there were no 
major differences in the polyadenylation sites used or the ratios between the sites used by 
either species.  An alignment of the two mRNAs showed that the regions containing the 
polyadenylation sites aligned at exactly the same location.  Since trypanosomatids utilize 
multiple polyadenylation sites (143), it is conceivable that this could include or exclude 
elements in the 3ʹUTR responsible for stability, but this does not appear to be the manner 
in which LHR1 is regulated.  There is also the possibility of alternative SL-acceptor site 
usage in controlling gene expression.  It was previously shown that alternative SL-
acceptor sites were not used by LHR1 in L. amazonensis when parasites were grown 
under normal conditions and under iron deplete conditions (144), so we focused our 





Luciferase Reporter Gene Assays 
 Given the differences in the 3ʹUTRs of the two mRNAs, we asked if these 
differences were involved in the differential regulation of LHR1 mRNA levels that we 
had observed.  We generated luciferase reporter constructs that had the luciferase gene 
flanked by the 5ʹUTR and 3ʹUTR regions from either L. amazonensis or L. chagasi LHR1 
(Figure 19 A).  These constructs were transfected into L. amazonensis and luciferase 
activity was measured upon heme depletion.  We hypothesized that the luciferase gene 
would respond in the same manner as LHR1 upon heme deprivation due to the presence 
of the LHR1 UTRs flanking the luciferase gene.  As a pilot experiment, we tested L. 
amazonensis transfected with the construct that had the luciferase gene under the control 
of the UTRs from L. amazonensis ([LamUTRs-luc]).  We grew these isolates under 
regular or heme-depleted conditions for 24 h and then measured luciferase activity 
(Figure 19 B).  Even though the luciferase activity was slightly higher under the heme-
depleted conditions, it was not significant.  This is not what we would expect to see upon 
 
Figure 18 – LHR1 ORF and 3ʹUTR Alignments of L. amazonensis and L. chagasi.  Alignment 
showed 83% identity between the transcripts with polyadenylation (poly(A)) sites at approximately the 




heme deprivation since we know that LHR1 transcripts are 4-fold higher when these 
parasites are grown in heme-depleted media and they take up ZnMP faster than parasites 
grown in regular media (35).  Consequently we ran a RT-qPCR on the RNA isolated 
from the parasites that were grown under the same conditions to verify what was 
occurring at the transcript level.  We found that the luciferase mRNA was higher in 
heme-depleted conditions, as would be expected, but the nourseothricin resistance gene 
(Sat) mRNA increased to the same extent as the luciferase mRNA (Figure 19 C).  This 
luciferase reporter construct was episomally expressed in theses parasites and this data 
suggests that the stress of heme deprivation caused the entire plasmid to be transcribed 
more and not specifically just the luciferase gene, so the increase in luciferase transcripts 
was probably not due to the presence of the LHR1 UTRs on the transcript.  Consequently, 
it would be difficult to use this experimental set-up to verify if the UTRs are involved in 
gene regulation.  Recently tools were constructed that would allow for the integration of 
this luciferase construct into the LHR1 loci, which could potentially overcome the overall 
transcription increase of the episome that we observed and allow us to clarify if the 
3ʹUTRs are involved in the gene regulation of LHR1 (145).  Using this new approach, we 
can integrate the L. chagasi and L. amazonensis UTR-Luc constructs into the genomes of 
L. chagasi and L. amazonensis and then measure luciferase activity and luciferase mRNA 
levels upon heme deprivation.  If the differences in the UTRs are involved in gene 
regulation, we would expect to see higher luciferase activity when the luciferase gene is 








 We showed that L. chagasi has higher LHR1 transcript levels than L. amazonensis 
when grown under heme-depleted conditions, and that these higher transcript levels 
 
Figure 19 – Luciferase Reporter Assays using LHR1 UTRs from L. amazonensis and L. chagasi.  
A) Schematic of the plasmids constructed.  B) Luciferase activity detected in L. amazonensis + 
[LamUTRs-luc] after growth for 24 h in heme-depleted medium.  Assay was done in duplicate and 
experiment was repeated 4 times.  Errors shown are standard deviations.  C) qPCR data generated using 
mRNA isolated after growth in heme-depleted medium for 24 h.  Fold changes in light blue are when 
C(t) values were normalized to Sat (on plasmid) and those in light green are when normalized to UbH 




correlate with ZnMP uptake over time, with L. chagasi showing higher fluorescence at 
earlier time points than L. amazonensis.  Examination of the LHR1 genomic locus of 
these two closely related species showed that the ORF is well conserved as are the UTRs, 
although there are some detectable differences in the 3ʹUTRs.. 3ʹUTRs have been shown 
to be involved in gene regulation in a number of genes in Leishmania including heat 
shock proteins, amastin surface proteins, and paraflagellar rod proteins via tertiary 
structure of the mRNA or conserved motifs that can bind regulatory proteins 
(117,125,146).  The differences observed in the 3ʹUTRs at the LHR1 genomic locus led 
to the characterization of the polyadenylation addition sites for the LHR1 genes from L. 
chagasi and L. amazonensis.  There were no significant differences in polyadenylation 
addition sites between the two species and neither the sites nor their usage ratios changed 
upon growth in heme-depleted conditions.  Attempts to verify whether the differences in 
the 3ʹUTRs were responsible for the modulation of LHR1 transcript levels upon heme 
depletion using luciferase reporter constructs failed to reveal any differences in luciferase 
activity under the conditions examined.  
 These data suggest that there are fundamental differences in the manner in which 
L. chagasi and L. amazonensis regulate heme acquisition and LHR1.  Given the high 
degree of similarity between the LHR1 proteins from these two species, the observed 
differences are probably not due to intrinsic characteristics of the proteins themselves, but 
could be related to differential post-transcriptional regulation.  We showed that there 
were no major differences in polyadenylation sites between the two species in regular or 
heme-depleted conditions, indicating that differential mRNA processing is not likely to 




transcriptional regulation present in trypanosomatid parasites is likely to be responsible 
for the differences we observed. 
 To our knowledge, this is the only study that has been performed investigating the 
differential heme acquisition in L. chagasi and L. amazonensis.  Heme acquisition in L. 
amazonensis (35), as well as some other trypanosomatids (90,91) has been described, but 
other species of Leishmania have not been examined.  A kinetic analysis of heme uptake 
in multiple Leishmania spp. still needs to be performed in order to compare heme 
acquisition between species that are associated with cutaneous leishmaniasis and species 
that are associated with visceral leishmaniasis. 
 The underlying mechanisms behind the differences observed between visceral and 
cutaneous strains remain elusive.  An understanding of the mechanisms and traits that 
cause or allow one species and not another to visceralize might allow us to design better 
treatments for individuals already infected and potentially intervene with preventative 
measures before infection occurs.  In order to characterize the potential heme acquisition 
differences between visceral and cutaneous strains further, a study of additional 
visceralizing (L. donovani, L. tropica, L. siamensis, etc.) and cutaneous (L. major, L. 
pifanoi, L. peruviana, etc.) species needs to be done.  It would also be of great interest to 
identify the mechanism by which heme acquisition is regulated in these different species, 
and if modulation of the heme acquisition pathway could alter the outcome of disease.  It 
would be particularly interesting, as suggested by our initial results with L. chagasi, if 
Leishmania species that can leave the skin to invade deep organs during visceralization 




is a major difference between visceral and cutaneous species it would provide a new 




Chapter 4: Mutagenesis Analysis of LHR1 
Adapted from Renberg et al. Manuscript in preparation. 
Introduction 
 Iron and heme are both essential nutrients for growth of Leishmania.  Leishmania 
parasites have two life cycles stages that grow in two different hosts and occupy two 
vastly different environments, the gut of sand fly and the PV within macrophages, that 
have different pH values, temperatures, nutrient availability, etc. (147-150).  These two 
environments potentially contain different concentrations of available heme and iron.  It 
is logical then, that these parasites have evolved many different mechanisms for 
acquiring these essential nutrients. The availability of iron is known to have a profound 
effect on the outcome of infection, and it has been demonstrated that parasites alter 
macrophage iron import and export pathways and that infected macrophages bind more 
hemoglobin via CD163 than non-infected macrophages, thus allowing the parasites to 
acquire these two important nutrients (22,23,34,151-153).  Gaining an understanding of 
heme acquisition pathways of this medically important parasite will provide insight into 
its biology and possibly provide targets for new drug development (154). 
 Heme binding proteins have been described in bacteria and in metazoans.  In 
bacteria many proteins of the cytochrome c maturation pathway have been characterized 
that transport heme via interactions with histidine residues (155-163).  Three metazoan 
heme transporters have been characterized in order to identify the amino acid residues 
that are involved in heme transport.  Two heme transporters from C. elegans, CeHRG-1 




heme transport, and the human homologue of CeHRG-1, hHRG-1, utilizes a histidine 
residue in a transmembrane domain for heme transport (62).  None of the heme 
transporters that have been identified in trypanosomatid parasites have been characterized 
to identify the amino acid residues involved in heme transport.  Here we present a 
mutagenesis analysis of LHR1 and show for the first time that key tyrosine residues but 
not histidine residues are important for heme transport. 
Results 
Selection of Amino Acid Residues for Mutagenesis Analysis in LHR1 
 LHR1 was originally identified by its homology with CeHRG-4, small size, and 
predicted structure of four transmembrane domains (35).  The Hamza group, which 
discovered and characterized CeHRG-4 and CeHRG-1 (61), also identified the amino 
acid residues that are important for heme transport (62).  They found that in CeHRG-4 a 
histidine in extracellular loop 2 (His-108) and the c-terminal FARKY motif, the potential 
heme interacting cluster of basic and aromatic amino acids, were important for heme 
transport, and in CeHRG-1 a histidine in transmembrane domain 2 (His-90) and the c-
terminal FARKY motif were important for heme transport (62).  LHR1 has a homologous 
histidine (His-105) to CeHRG-4 His-108, but the FARKY motif is not present in LHR1 
so it is probable that LHR1 utilizes different amino acids in the C-terminus to mediate 
transport.  Based on the mutagenesis analysis of CeHRG-4, research done on bacterial 
heme binding proteins (164,165), and residues that could participate in disulfide bonds, 
we selected nine LHR1 amino acids for mutation analysis: Tyr-18, His-36, Tyr-64, Tyr-
80, His-105, Arg-106, Tyr-129, Tyr-136, and Cys-174 (Figure 20 A, B).  We selected 




shown to participate in heme transport (62).  Next we selected various histidines and 
tyrosines throughout the protein (Tyr-18, His-36, Tyr-64, Tyr-80, Try-129, Tyr-136) 
based on findings showing that these amino acids can be involved in heme coordination 
(164).  Finally we selected the only cysteine residue (Cys-174) because of its potential 
involvement in disulfide bond formation and intermolecular interactions.  All amino acid 
residues were mutated to alanine and mutant proteins were examined for phenotypes. 
 
    
Figure 20 – Selection of Amino Acid Residues for Mutagenesis Analysis in LHR1.  A) Alignment 
of CeHRG-4 with L. amazonensis (LmxA) LHR1 and LHR1 homologues from L. major (LmjF) and L. 
infantum (LinJ) highlighting the residues selected for mutation analysis; light blue indicates residues 
found to be important in C. elegans HRG-4; orange indicates residues selected for mutagenesis in L. 
amazonensis; light gray boxes indicate transmembrane domains.  B) Predicted structure of LHR1 with 
amino acids selected for mutation highlighted to show their location in the predicted structure of LHR1; 




Tyrosines 18, 80, & 129 are Important for LHR1 Function 
Despite extensive efforts, we were unable to generate a homozygous LHR1 
knockout in L. amazonensis, which made the use of L. amazonensis unsuitable for a fast 
and efficient screen of the mutant proteins for phenotypes (35).  Consequently we used a 
heterologous system that would allow us to characterize the ability of the mutant proteins 
to transport heme without interference from endogenous heme transporters.  We took 
advantage of S. cerevisiae because it utilizes exogenous heme poorly (even when it lacks 
an essential enzyme in the heme biosynthetic pathway), doesn’t contain LHR1 homologs, 
and there are many mutant strains available.  We used the S. cerevisiae Δhem1 (6D) 
strain, which lacks the HEM1 gene that encodes the first enzyme in the heme 
biosynthesis pathway, δ-aminolevulinic acid synthase (ALAS) (62,166).  The Δhem1 
(6D) strain needs to be supplemented with the product of ALAS, δ-aminolevulinic acid 
(ALA), or excess hemin (≥ 10 µM) in order to grow.  LHR1 WT and mutant proteins 
tagged at the C-terminus with an HA epitope were expressed in the Δhem1 (6D) strain 
under the inducible GAL1 promoter.  We used two independent assays already well 
established in the Δhem1 (6D) strain to assess the ability of the LHR1 WT and mutant 
proteins to transport heme (166). First, we assessed the rescue of growth of the Δhem1 
(6D) strain transformed with plasmids expressing LHR1 or the lhr1 mutants on agar 
plates containing varying heme concentrations (Figure 21 A).  Cells transformed with 
pYES-DEST52 alone were only able to grow on agar plates when supplemented with 
ALA or ≥1 µM heme.  In contrast, cells transformed with WT LHR1 were able to grow at 
0.25 µM heme.  At 0.25 µM heme, cells transformed with Y18A, Y80A, and Y129A 




all other mutants showed no significant difference in growth pattern when compared to 
cells expressing WT LHR1 (Figure 21 A).  There were some variations in expression 
levels between the mutant proteins, but the majority expressed at levels comparable to 
WT, with H36A being the only one with significantly higher expression levels, which 
may account for the increased growth observed in the growth spot assay (Figure 21 A,B).  
Second, we measured changes in regulatory intracellular pools of heme using β-
galactosidase activity from a CYC::lacZ promoter-reporter fusion.  In this system, lacZ 
expression is dependent upon Hap1-5, a transcription complex that binds heme and 
activates the CYC1 promoter; consequently the level of β-galactosidase activity directly 
correlates to the amount of intracellular heme that is available to activate the CYC1 
promoter (62).  Cells transformed with pYES-DEST52 alone had negligible cytoplasmic 
heme levels, but cells transformed with WT LHR1 had increased cytoplasmic heme 
levels.  Cells expressing Y18A, Y80A, R106A and Y129A mutants had significantly 
decreased cytoplasmic heme levels at both concentrations of heme tested when compared 
to cells expressing WT LHR1.  Cell expressing H36A showed an increased level of 
cytoplasmic heme when compared to WT LHR1 only when grown in 10 µM heme.  All 
other mutations assayed did not alter the cytoplasmic heme levels to a significant extent 





         
Figure 21 – Tyrosines 18, 80, & 129 are Important for LHR1 Function.  A) Cells expressing LHR1, 
WT or mutant proteins, were serially diluted and spotted onto agar plates with varying concentrations of 
heme or 250 µM ALA and incubated at 30°C for 4 days and then imaged.  Experiment was repeated 2-4 
times with independent transformants.  B) Western blot of S. cerevisae lysates transformed with LHR1, 
WT or mutant, grown in 10 µM heme.  C) β-galactosidase reporter assay performed in yeast grown in 
either 1 or 10 µM hemin for 16 h.  Experiment was repeated 5-8 times with independent transformants.  




Tyrosines 18, 80, & 129 are Not Required for Promastigote Growth in Complete Medium 
Based on the results of the mutant screen performed in yeast, we selected four 
mutations, Y18A, H36A, Y80A, and Y129A, to characterize in L. amazonensis.  
Constructs contain WT LHR1 and mutant lhr1 were transformed into L. amazonensis 
Δlhr1/LHR1 (SKO) promastigotes and isolates were selected that had comparable 
expression levels (Figure 22 B).  Multiple Y18A clonal isolates were tested, and all 
showed lower expression levels when compared to WT and the other mutants.  SKO 
isolates expressing WT LHR1 or the mutant lhr1 proteins showed no growth defect in 
regular PGM (Figure 22 A). 
 
                 
Figure 22 – Tyrosines 18, 80, & 129 are Not Required for Promastigote Growth but are 
Important for Heme Transport in L. amazonensis.  A) Isolates were grown in regular PGM and 
growth followed over time.  Experiment was repeated twice with consistent results.  B) Western Blot 




Tyrosines 18, 80,  & 129 are Necessary for Virulence in Macrophage Infections 
 To this point we had investigated the role of the mutant LHR1 proteins in the 
promastigote form. To determine whether these mutations were important for growth of 
the intracellular amastigote form, bone marrow-derived macrophages (BMM) were 
infected with axenic amastigotes of heterozygous Δlhr1/LHR1 (SKO) L. amazonensis and 
SKO complemented with WT, Y18A, H36A, Y80A, or Y129A lhr1 and intracellular 
parasites were quantified after 1, 36, and 72 hours post infection (Figure 23 A).  
Consistent with previous observations (84), SKO parasites fail to grow in BMMs but 
growth can be partially restored in parasites that episomally express LHR1, which 
undergoes two replication cycles by 72 h post infection.  SKO parasites expressing 
Y18A, Y80A, and Y129A failed to rescue intracellular growth and don’t complete one 
full replication cycle by 72 hours post infection.  SKO parasites expressing H36A had 
growth comparable to the of SKO expressing WT and undergo one full replication cycle 
by 72 hours post infection (Figure 23 A,B).  The growth defect in parasites expressing the 
Y18A mutant was comparable to the growth defect of SKO parasites without 
complementation, indicating that Y18A might be a non-functional protein or might not be 
expressed at levels high enough in order to observe its contribution over the background 
of the endogenous LHR1 in the SKO strain.  On the other hand, Y80A and Y129A did 
not rescue growth to the same extent as WT but grew better than SKO, suggesting that 






                   
Figure 23 – Tyrosines 18, 80, & 129 are Necessary for Virulence in Macrophage Infections.  A) 
SKO and SKO + WT/Y18A/H36A/Y80A/Y129A LHR1-HA were transformed into axenic amastigotes 
and used to infect BMMs from C57BL/6 mice; growth was followed over time.  Assay was performed 
in triplicate and graph is representative of three experiments; * p ≤ 0.05, ** p ≤ 0.01; Student’s t-test at 
72 h: WT vs. SKO = 0.005, WT vs. Y18A = 0.004, WT vs. H36A = 0.06, WT vs. Y80A = 0.01, WT vs. 
Y129A = 0.04; at 36 h: WT vs. Y18A = 0.03  B) Immunofluorescence images of infected macrophages 




Tyrosines 18, 80, & 129 are Essential for Virulence in vivo 
 To determine the effect of these mutations on in vivo infectivity, axenic 
amastigotes were injected in the left hind footpad of C57BL/6 mice and lesion 
development was followed over a 10-week period with parasites loads calculated at week 
10.  Consistent with previous observations (84), SKO parasites fail to form a lesion and 
have low parasite loads.  SKO parasites complemented with WT LHR1 or H36A lhr1 
were able to restore lesion development but not to wild type L. amazonensis levels 
(Figure 24 A,B) consistent with earlier findings (84).  In agreement with the growth 
profiles observed in the macrophage infections, Y18A, Y80A, and Y129A all showed 
smaller lesion development and lower parasite loads when compared to WT LHR1 
(Figure 24 A,B).  Interestingly, Y18A had an even lower parasite load than SKO without 
complementation, suggesting that even at low expression levels this mutant is severely 






               
Figure 24 – Tyrosines 18, 80, & 129 are Essential for Virulence in vivo.  A) Lesion growth over time 
of C57BL/6 mice infected with L. amazonensis (Lam), SKO, SKO+LHR1 (WT), SKO+Y18A (Y18A), 
SKO+H36A (H36A), SKO+Y80A (Y80A), or SKO+Y129A (Y129A).  Inset shows the growth of Lam 
compared to SKO and WT; axes are the same as the large graph.  Each group had 5 mice and 
experiment was performed once.  B) Total parasite load isolated from lesions after 10 weeks of 
infection.  Each group had five mice.  Student’s t-test values: WT vs. SKO = 0.002; WT vs. Y18A = 





 A mutagenesis analysis of L. amazonensis LHR1 was performed in order to gain 
an understanding of the molecular mechanisms responsible for heme transport due to 
LHR1 in these parasites.  Amino acid residues were selected for mutagenesis based on 
their alignment to residues known to be important for protein function in CeHRG-4 (62), 
their predicted interaction with heme, or their potential to form disulfide bonds.  Four 
mutants of interest emerged from the yeast screen: three reduced heme transport function, 
Y18A, Y80A, and Y129A, and one appeared to increase heme uptake function, H36A 
(Figure 21).  The expression level of H36A in the yeast assays was always consistently 
higher than all of the other mutant proteins, so we cannot rule out the possibility that the 
increase in function observed is due to more protein being present, and not an inherent 
change in the transporter caused by the mutation.  These four mutant proteins were then 
expressed in L. amazonensis to verify the importance of these amino acids for LHR1 
function in its native environment.  None of the mutant proteins showed a phenotype in 
promastigote forms, but Y18A, Y80A, and Y129A all failed to rescue intracellular 
growth in BMM infections (Figure 23), and were important for in vivo footpad infection 
in mice with all three unable to rescue lesion growth or parasite loads to a comparable 
level to that of wild type LHR1 protein (Figure 24). 
Histidines are known to be important in other heme transporters (62), and even 
though H36A had an interesting phenotype in the yeast screen, it failed to show a 
phenotype in L. amazonensis when its expression level was comparable to the other 
mutant proteins.  Therefore, the apparent gain of function phenotype that was observed in 




of LHR1 function.  The histidine in LHR1 (His-105) homologous to the histidine known 
to be involved in CeHRG-4 function (His-108), showed no phenotype in the yeast screen 
(Figure 21).  We mutated the other histidine in LHR1 (His-36) and it also did not show 
decreased function in the yeast.  This result suggests that LHR1 does not employ 
histidines to form a complex with heme during transport, but instead utilizes alternative 
amino acids. 
Tyrosines have been shown to coordinate with heme as well (167,168).  Y18A 
consistently showed decreased function in yeast and Leishmania experiments; even 
though the expression levels were lower than the other mutant proteins examined in 
Leishmania, these low levels of expression were sufficient to give an intriguing result in 
the parasite load calculations in mouse infection experiments.  Not only did Y18A fail to 
develop a lesion in mouse footpad infections, the parasite loads were lower than SKO; 
suggesting that Y18A may do more than render LHR1 non-functional because if Y18A 
was just non-functional it would be expected to have parasite loads similar to that of 
SKO.  One interesting possibility, to be tested in future studies, is that the Y18A may 
have a dominant-negative effect, perhaps interfering with proper LHR1 oligomerization.  
Y80A and Y129A consistently decreased LHR1 function in both yeast and Leishmania 
assays.  These tyrosine residues are located in transmembrane domains at positions where 
they could potentially coordinate with heme as it is transported across the membrane.   
 These findings are important because an understanding of heme acquisition in 
Leishmania is essential if therapeutics targeting this pathway are to be developed.  New 
therapeutic drugs are urgently needed in order to combat these serious global human 




and acquisition of heme from the environment is essential for Leishmania survival.  
There are no known homologues of LHR1 in humans, which decreases the possibility of 
off target effects if small molecule inhibitors to LHR1 can be developed. 
 With this study we have added to our understanding of the mechanisms involved 
in heme transport by the parasite Leishmania, but there is much that remains unknown.  
LHR1 is a small protein of only 175 amino acids with four predicted transmembrane 
domains that probably does not have the necessary size to form a transmembrane channel 
large enough to accommodate heme.  We still do not know if LHR1 functions as a 
monomer or an oligomer and what the implications of that would be on our 
understanding of heme acquisition in these parasites.  It would also be important to 
understand how LHR1 obtains the energy to transport heme against a concentration 
gradient.  LHR1 doesn’t contain any ATP-binding cassettes, but this doesn’t rule out the 
possibility that heme transport by LHR1 could be ATP dependent, as heme transport may 
be coupled to an ATP-dependent process.  There is some initial evidence that heme 
uptake in T. cruzi is dependent upon ATP (90), but whether this uptake observed in T. 
cruzi is due to the LHR1 homologue or to an alternative heme acquisition pathway via 
hemoglobin breakdown is unknown (91).  Further research is necessary to have a 
comprehensive understanding of the role of LHR1 in heme acquisition in Leishmania and 
the other Trypanosomatidae family members, and how this protein might be exploited for 





Chapter 5:  Conclusions and Future Directions 
The aim of this dissertation was to characterize Leishmania Heme Response 1 
(LHR1) as a heme transporter and to gain an understanding of the molecular mechanisms 
responsible for heme transport.  LHR1 is responsible for heme uptake in L. amazonensis 
and appears to bind heme in a pH independent manner, but transport heme more 
effectively in acidic pH (Chapter 2).  L. amazonensis and L. chagasi differentially 
regulate LHR1 and have different kinetics of ZnMP uptake after heme deprivation, which 
could be due to the differences in the 3ʹUTRs between the two species (Chapter 3).  
Three tyrosine residues, Tyr-18, Tyr-80, & Tyr-129, were found to be important in LHR1 
function and due to their proximity to the cytoplasmic leaflet of the plasma membrane 
may play a direct role in heme binding and transport (Chapter 4). 
There is a critical need for new therapeutics in the treatment of leishmaniasis, and 
a greater understanding of the basic biology of Leishmania is needed in order to develop 
safe and effective drugs.  This dissertation provides evidence about how the heme 
transporter LHR1 functions, and adds to our understanding of Leishmania biology by 
providing insight into how these parasites acquire an essential nutrient, heme.  This 
understanding of the molecular mechanisms involved in heme transport could provide a 
blueprint for development of novel therapies. 
Even though there has been extensive research conducted on heme acquisition in 
Leishmania, many questions remain.  We do not understand how LHR1 obtains the 
energy needed to transport heme across the membrane, as it is probably necessary to 
transport heme against a heme concentration gradient.  The energy for heme transport 




evidence that addition of ATP inhibitors reduces the total intracellular heme 
concentration in T. cruzi (90), but whether this reduction in intracellular heme is due to 
the inhibition of the LHR1 homologue is not known because T. cruzi can use hemoglobin 
as a heme source, and this pathway may be the one that is ATP-dependent (90,91,172).  
Since Leishmania appear to have two known pathways for acquiring heme, direct heme 
transport by LHR1 and hemoglobin breakdown followed by heme transport via 
LABCG5, it is necessary to develop a highly sensitive kinetic uptake assay to distinguish 
between these two pathways, to identify which is the major pathway for heme acquisition 
utilized by Leishmania promastigotes and amastigotes, and to identify the energy 
source(s) necessary for each pathway (54).  Some evidence that LHR1 may be 
independent of ATP is that hHRG-1 has been shown to associate with the vacuolar H+-
ATPase (V-ATPase) proton pump, suggesting that a proton gradient generated via V-
ATPases may drive heme transport for HRG-1-related proteins (62,63). 
Another important aspect that needs to be clarified is if LHR1 is functioning as an 
oligomer and how oligomerization is mediated, in order to provide understanding on how 
heme transporters function at the molecular level and provide direction for drug 
development.  Disruption of the potential oligomerization of LHR1 could interfere with 
heme transport, thus providing an additional target for drug development. 
Our understanding of differences between visceral and cutaneous Leishmania 
species continues to be limited.  It would be of interest to expand the investigation of the 
difference in heme acquisition between visceral and cutaneous species with a focus on 
how that differential acquisition is mediated.  If heme acquisition is an important 




optimal heme concentration for growth of a visceral or cutaneous species, which has not 
been experimentally determined.  An understanding of how LHR1 expression is regulated 
would also aid this avenue of investigation, and provide much needed understanding in 
the parasitology field of mechanisms of gene regulation in Leishmania. 
 LHR1 is essential for virulence and appears to be most important in intracellular 
amastigote forms, because that is where the most severe growth phenotype is observed 
(35,84).  It would be useful to measure the total intracellular heme concentrations and the 
expression levels of LHR1 in intracellular and axenic amastigotes, for comparisons with 
what we know about the promastigote forms.  It is also of interest to understand what role 
the tyrosine residues are playing in the function of LHR1.  Based on their predicted 
position in the transmembrane domains near the cytoplasmic leaflet of the plasma 
membrane, we hypothesize that these tyrosines would be involved in coordinating with 
heme during the transport process and would not be directly involved in the initial 
binding of heme to LHR1.  The evidence for the involvement of tyrosines in this process 
argues against the possibility that the tyrosine mutations interfered with proper folding 
and targeting of LHR1.  There are other tyrosines in LHR1 that are located within 
transmembrane domains closer to the extracellular leaflet of the plasma membrane that 
could act as the initial coordinators of heme and then pass the heme through the 
transmembrane domain to the next set of coordinating tyrosines.  There are two computer 
programs available for predicting if amino acid residues can interact with heme, 
HemeBIND and PSSMPP (173,174).  We used HemeBIND (173), freely available on 
line at http://mleg.cse.sc.edu/hemeBIND, to predict which amino acid residues could 




throughout LHR1 could interact with heme.  Tyr-18 and Tyr-80 were predicted to interact 
with heme while His-36 and Tyr-129 were not likely to interact with heme.  These 
programs could be useful in guiding future investigations to help identify the amino acids 
important for binding of heme and those important for transport. 
 This dissertation has provided evidence about the molecular mechanisms involved 
in heme acquisition via LHR1 in L. amazonensis and has presented data concerning 
differential heme acquisition in representative visceral and cutaneous species.  Although 
further research is needed in order to understand the role of LHR1 in heme acquisition 
and parasite survival, these data establish a basis for further studies.  There are LHR1 
homologues present in many Leishmania and Trypanosoma species and a broad-spectrum 






Materials & Methods 
Parasite Cultures – L. amazonensis IFLA/BR/67/PH8 strain was provided by Dr. David 
Sacks (Laboratory of Parasitic Diseases, NIAID, NIH).  L. amazonensis Δlhr1/LHR1 
(SKO) was generated by Dr. Chau Huynh as described (35).  L. chagasi Sau Paulo was 
provided by Dr. David Sacks.  L. amazonensis parasites were cultured at 26°C in 
promastigote growth medium (PGM): M199 (Gibco BRL; Cat. #11825-015) pH 7.4 
supplemented with 40 mM HEPES, 0.1 mM adenine, 0.00001% biotin, 0.0005% hemin 
(7.6 µM), 20 % heat-inactivated FBS, 5 mM L-Glutamine, and 5% penicillin-
streptomycin. L. chagasi parasites were culture at 26°C in promastigote growth medium 
(LcPGM): M199 pH 6.8 supplemented with 25 mM HEPES, 4.2 mM sodium 
bicarbonate, 1X RPMI Vitamin Mix (Sigma; R7256), 23 µM folic acid, 100 µM 
adenosine, 10% heat-inactivated FBS, and 5% penicillin-streptomycin as described 
elsewhere (175). 
 
Heme Depleted FBS - Heat-inactivated FBS was treated with 10 mM (+)-Sodium L-
ascorbate (Sigma; Cat. # A-7631) overnight at room temperature, followed by three 
rounds of dialysis with PBS+/+ and filter-sterilization.  Heme depletion was verified by 
measuring the optical absorbance at 405 nm (176). 
 
Yeast Strains and Growth Media - The Saccharomyces cerevisiae strain Δhem1 (6D) 
strain was constructed as described elsewhere (92).  Cells were maintained in YPD (yeast 








Radioactive Heme Uptake – Mid log promastigotes of L. amazonensis WT were grown 
O/N in regular of heme-depleted PGM.  Parasites were washed and resuspended in 
binding buffer (HBSS without Ca2+/Mg2+, pH 5.5, 1% BSA) at 1.25 x 108 parasites/ml.  5 
x 107 parasites were used for each time point in triplicate.  ~200 pmol of 55[Fe]-heme was 
added to the samples.  Samples were incubated at 26 °C for the indicated time.  Reaction 
was stopped by adding an equal volume of cold quench/wash buffer (HBSS pH 7.4, 5% 
BSA, 1 µM cold hemin chloride).  Cells were washed twice with wash buffer and once 
with HBSS.  Cells were hydrolyzed with 1 N NaOH at 50 °C, then placed into 
scintillation vials with scintillation fluid for counting.  Samples were read on a Beckman 
LS 6500 Multipurpose Scintillation Counter.  Counts were normalized to paired samples 
at 0 °C. 
 
Chapter 2 
Total Intracellular Heme Concentrations – Concentrations of heme were determined 
using the pyridine hemochrome method (177).  4 x 109 promastigotes growing in mid-log 
phase in regular promastigote growth medium were collected via centrifugation, counted, 
washed once with PBS, and resuspended in 1 ml 1 mM Tris-HCl pH 8.0 and sonicated 
twice for 2 min in an ice water bath with a Branson digital sonifier at 30% amplitude, in 




13x100 mm glass tubes and 100 µl of 1 N NaOH was added followed by vortexing.  
After 2 min, 200 µl of pyridine (Sigma-Aldrich; Cat. # P57506) was added followed by 
vortexing.  Samples were transferred to a 1 ml cuvette and a baseline absorbance 
spectrum between 500 and 600 nm was acquired.  A few crystals of sodium hydrosulfite 
(2-3 mg) (Sigma-Aldrich; Cat. # 71699) were added to the samples and after 1 min the 
reduced hemochrome absorbance spectrum between 500 and 600 nm was acquired.  
Heme concentrations were then calculated based on the millimolar extinction coefficient 
of 20.7 using the difference in the absorption spectra at 557 nm (peak) and 541 nm 
(valley); [heme] mM = (OD557nm – OD541nm)/20.7 
 
ZnMP Uptake Assay in Yeast - pYes-DEST52-LHR1-HA and pYes-DEST52 (vector 
control) were transformed into the Δhem1 (6D) strain using the lithium acetate method 
(178).  Transformants were selected on 2% w/v glucose SC (-Ura) plates supplemented 
with 250 µM ALA.  Eight to ten colonies were picked and grown over night in YPD 
supplemented with 250 µM ALA and 40 mg/l adenine. The cells were resuspended in 2% 
w/v glucose SC (-Ura) supplemented with 250 µM ALA and 40 mg/l adenine and 
incubated at 30°C for 24 h.  Cells were resuspended in 2% w/v raffinose SC (-Ura) 
supplemented with 250 µM ALA and 40 mg/l adenine and incubated at 30°C for 18 h to 
deplete of glucose. Cells were washed once with PBS and resuspended in 2% w/v 
galactose SC (-Ura) supplemented with 40 mg/l adenine and incubated over night at 30°C 
to deplete of heme and induce LHR1 expression.  Cells were washed once with 
PBS+BSA (1 g/l), resuspended in PBS+BSA and placed at 30°C or 4°C for 20 min to 




from a stock of 10 mM in DMSO to a final concentration of 100 µM.  Hemin (Frontier 
Scientific; Cat. # H651-9) was added to appropriate tubes from a stock of 10 mM in 0.3M 
ammonium hydroxide to a final concentration of 1000 µM.  Cells were maintained at the 
respective temperatures with rotation until aliquots were taken at 20, 40, 60, and 90 min.  
Cells were washed twice with PBS+BSA at 4°C and placed in pre-chilled 5 ml BD 
Falcon FACS tubes on ice.  1 X 106 cells per sample were examined using a flow 
cytometer (BD FACSCanto, excitation at 488 nm and emission equal or greater than 670 
nm) and data for 10,000 events were collected.  Samples were gated at 102.2 with left of 
the line considered negative and right of the line positive.  Baseline fluorescence was 
considered to be the empty vector at 30°C with ZnMP and this baseline fluorescence 
value was subtracted from total values for each sample and plotted as % fluorescence vs. 
time.  Experiment was repeated twice with consistent trends. 
 
Potential Δlhr1/Δlhr1 PCR - Genomic DNA from potential Δlhr1/Δlhr1 clones 
expressing [pXGSAT-LHR1-3xFLAG] that were resistant to hygromycin B (100 µg/ml), 
nourseothricin (50 µg/ml), and G418 (50 µg/ml) was isolated in TELT lysis buffer as 
previously described (179).  PCR reactions were performed in a BioRad Thermocycler 
using OneTaq Hot Start DNA Polymerase (New England BioLabs) according to the 
manufacturer’s instructions.  PCR reactions were run on a 1% agarose gel using GelRed 




































Radioactive Heme Uptake – Mid-log promastigotes of L. amazonensis WT or SKO were 
grown O/N in regular of heme-depleted PGM.  Parasites were washed and resuspended in 
binding buffer (HBSS without Ca2+/Mg2+, pH 5.5, 1% BSA) at 1.25 x 108 parasites/ml.  5 
x 107 parasites were used for each time point in triplicate.  ~200 pmol of 55[Fe]-heme was 
added to each sample.  Samples were incubated at 26 °C or 0 °C for 60 min.  Reaction 
was stopped by adding an equal volume of cold quench/wash buffer (HBSS pH 7.4, 5% 
BSA, 1 µM cold hemin chloride).  Cells were washed twice with wash buffer and once 
with HBSS.  Cells were hydrolyzed with 1 N NaOH at 50 °C, then placed into 
scintillation vials with scintillation fluid for counting.  Samples were read on a Beckman 
LS 6500 Multipurpose Scintillation Counter.  Counts were normalized to paired samples 





Hemin Agarose Binding – Mid-log phase L. amazonensis [pXGSAT-LHR1-3XFLAG] 
grown in PGM were lysed with modified MS Buffer (210 mM mannitol, 70 mM sucrose, 
0.5% NP-40, 25 mM MES/MOPS pH 5, 6, 7, or 8, 1X cOmplete protease inhibitor 
cocktail (Roche Cat. # 04693159001) at indicated pH values and passed through a 25 
gauge needle.  50 µg of total protein was added to 120 µl (300 nmol) hemin-agarose 
(Sigma; Cat. # H6390) or Sepharose 4B (Sigma; Cat. # 4B200).  Samples were incubated 
at room temperature with rotation for 30 min then washed well with wash buffer (150 
mM NaCl, 1% NP-40, 25 mM MES/MOPS pH 5, 6, 7, or 8).  Proteins were eluted from 
the beads with Thorner Sample Buffer and run on a 12% SDS-PAGE gel.  Proteins were 
transferred to nitrocellulose membrane (BioRad; Cat. # 162-0115).  Membranes were 
blocked with 5% milk, probed with anti-FLAG M2-HRP (Sigma; Cat. # A8592), 
developed with ECL (BioRad) and imaged on a FujiFilm LAS-3000 Imager.  
Densitometry analysis of bands was preformed using ImageJ.  Percentage total protein 
bound was calculated by dividing the intensity of bound band by the input band (adjusted 
based on total protein loaded on gel). 
 
Growth Spot Assay – Assay was performed as described previously (62) with some 
adaptation.  Briefly, Δhem1 (6D) were transfected with pYES-DEST52-LHR1-HA, 
pYES-DEST52-CeHRG-4 or vector alone using the lithium acetate method.  
Transformants were selected on 2% glucose SC (-Ura) plates supplemented with 250 µM 
ALA.  Five to seven colonies were picked and inoculated into 2% raffinose SC (-Ura) 
supplemented with 250 µM ALA and grown for 24 h at 30°C to deplete glucose and 




Ura) and grown O/N to deplete heme.  Prior to spotting, cultures were resuspended in 
water to OD600 of 0.2 and ten-fold serial dilutions were performed and10 ul of each 
dilution was spotted onto 2% raffinose SC (-Ura) plates buffed with 50 mM MES/MOPS 
at pH 5 or 6 supplemented with either 0.4% glucose with 250 µM ALA (positive control) 
or 0.4% galactose with 1 µM hemin or no hemin as negative control.  Plates were 
incubated at 30°C and imaged every day for five days. 
 
55[Fe]-Heme Binding and Uptake - Mid-log promastigotes of L. amazonensis WT were 
grown O/N in heme-depleted PGM.  Parasites were washed and resuspended in binding 
buffer (HBSS without Ca2+/Mg2+, pH 5.4 or pH 7.4, 1% BSA) at 1.25 x 108 parasites/ml.  
5 x 107 parasites were used for each condition in triplicate.  ~200 pmol of 55[Fe]-heme 
was added to each sample.  Samples were incubated at 26 °C or 0 °C for 60 min.  
Reaction was stopped by adding an equal volume of cold quench/wash buffer (HBSS pH 
7.4, 5% BSA, 1 µM cold hemin chloride).  Cells were washed twice with wash buffer and 
once with HBSS.  Cells were hydrolyzed with 1 N NaOH at 50 °C, then placed into 
scintillation vials with scintillation fluid for counting.  Samples were read on a Beckman 




RT-qPCR – Mid-log phase L. chagasi and L. amazonensis were grown for 24 h in regular 
or heme-depleted PGM.  RNA was isolated from 1x108 parasites for each condition using 




manufacturer’s instructions.  5 µg of RNA was used to generate cDNA using SuperScript 
III Reverse Transcriptase (Invitrogen; Cat. # 18080) according to the manufacturer’s 
instructions.  LHR1 transcript levels were quantified using 1 µl of cDNA per reaction in 
triplicate with specific primer sets for LHR1 and Ubiquitin Hydrolase (UbH) as the 
reference gene (see table below).  Primer sets were validated to find the optimal 
annealing temperature and PCR Efficiency.  Quantitative real time PCR was performed 
using PerfeCTa SYBR Green FastMix for iQ (Quanta Biosciences; Cat. # 95071) and the 
BioRad CFX96 Real-Time System C1000 Thermal Cycler (BioRad Laboratories) 
according to the manufacturer’s instructions.  The cycle threshold (Ct) values were 
determined and the 2-ΔΔCt was determined for each condition (180). 













ZnMP Uptake Assay in Leishmania – Mid-log cultures of L. chagasi and L. amazonensis 
were grown O/N in heme-depleted PGM.  10 µM ZnMP was added to each culture and 
cells were incubated at 26 °C.  Aliquots from each culture were taken at 0, 1, and 3 h and 
imaged live on an UltraVIEW VoX Spinning Disk Confocal Imaging System (Perkin 
Elmer) equipped with an Electron Multiplier CCD Camera (C9100-50; Hamamatsu).  
Images were acquired under identical acquisition settings and processed using the 
Volocity software suite (PerkinElmer).  Fluorescence intensity was measured for more 




Intensity was calculated per parasite.  Experiment was repeated twice with consistent 
results. 
 
Genomic Alignments – Genomic sequences for LmxM.24.2230 and LinJ.24.2320 plus the 
upstream and downstream genes (LmxM.24.2240 & LmxM.24.2220 for LmxM.24.2230 
and LinJ.24.2330 & LinJ.24.2310 for LinJ.24.2320) were downloaded from TriTrypDB 
(http://tritrypdb.org).  Sequences were aligned using Clustal Omega 
(http://www.ebi.ac.uk/Tools/msa/clustalo/). 
 
Polyadenylation Site Identification - mRNA was isolated from 1x108 parasites of mid-log 
L. chagasi and L. amazonensis using Macherey-Nagel NucleoSpin RNA kit (ClonTech 
Cat. # 740955) according to the manufacturer’s instructions.  The 3ʹ portion of LHR1 
mRNA was cloned following the 3ʹ RACE System for Rapid Amplification of cDNA 
Ends protocol (Invitrogen; Cat. # 18373-019) with an LHR1 specific primer 5ʹ – 
AACCGCATTGCATACCAGAC – 3ʹ.  Fragments were cloned into pCR2.1-TOPO 
using the TOPO TA Cloning Kit (Invitrogen; Cat. # 45-0046).  Plasmids were verified for 
insert and then sequenced. 
 
Luciferase Reporter Assays – [pF4X1.4-SAT-LamUTRs-luc] was generated using the In-
Fusion HD Cloning System (Clontech; Cat. # 639645).  [pCR2.1-TOPO-LamLHR1r] 
(LamLHR1 5ʹUTR = from the end of the upstream gene to the start of LHR1 and the 
LamLHR1 3ʹUTR = from the end codon of LHR1 to the start of the downstream gene) 




LHR1 gene using Platinum Taq DNA Polymerase High Fidelity (Invitrogen; Cat. # 
11304) = linearize vector.  The luciferase insert was amplified from pCR2.1-TOPO-
luciferase using the primers below. [pCR2.1-TOPO-LamLHR1-luc] was then generated 








using In-Fusion.  pCR2.2-TOPO-LamUTRs-luc was digested with BglII and NotI and the 
insert gel purified and ligated into [pF4X1.4-SAT] that has been digested with BglII and 
NotI using T4 DNA Ligase (NEB; Cat. # M0202) according to the manufacturer’s 
instructions.  [pF4X1.4-SAT-LamUTRs-luc] was then transformed into L. amazonensis 
and clones resistant to 50 µg/ml nourseothricin were selected.  L. amazonensis [pF4X1.4-
SAT-LamUTRS-luc] was grown for 24h in either regular or heme-depleted PGM.  1x108 
parasites were washed with PBS and then luciferase activity was detected using Promega 
Luciferase Assay System (Promega; Cat. # E1500) according to the manufacturer’s 
instructions.  Luciferase activity was read using a SpectraMax M5e (Molecular Devices) 
plate reader. 
 
RT-qPCR – Mid-log phase L. amazonensis [pF4X1.4-SAT-LamUTRs-luc] was grown in 
regular or heme-depleted PGM for 24 h.  RNA was isolated from 1x108 parasites for each 
condition using Macherey-Nagel NucleoSpin RNA kit (ClonTech Cat. # 740955) 
according to the manufacturer’s instructions.  5 µg of RNA was used to generate cDNA 




manufacturer’s instructions.  Luciferase, SAT1, LHR1, and Ubiquitin Hydrolase (UbH) 
transcript levels were quantified using 1 µl of cDNA per reaction in triplicate with 
specific primer sets (see table below).  Primer sets were validated to find the optimal 
annealing temperature and PCR efficiency.  Quantitative real time PCR was performed 
using PerfeCTa SYBR Green FastMix for iQ (Quanta Biosciences; Cat. # 95071) and the 
BioRad CFX96 Real-Time System C1000 Thermal Cycler (BioRad Laboratories) 
according to the manufacturer’s instructions.  The cycle threshold (Ct) values were 
determined and the 2-ΔΔCt was determined for each condition (180). 
























Alignment – C. elegans HRG-4 was provided by Dr. Iqbal Hamza (University of 
Maryland, Animal Sciences), L. amazonensis LHR1 sequence was performed in the 
Andrews’ lab, L. major and L. infantum LHR1 sequences were downloaded from 
TriTrypDB.  Sequences were aligned using Clustal Omega 
(http://www.ebi.ac.uk/Tools/msa/clustalo/).  Transmembrane domain predictions were 





Plasmid Constructs and Site-Directed Mutagenesis In Yeast – pYes-DEST52-LHR1-HA 
was constructed as described elsewhere (35).  Site-directed mutagenesis was performed 
on pYes-DEST52-LHR1-HA using the QuikChange Site-Directed Mutagenesis protocol 
(Agilent Technologies; Cat. # 200518); see table below for the list of primers used.  


















































Growth Spot Assay – pYES-DEST52-LHR1-HA and pYES-DEST52-LHR1-HA-
Y18A/H36A/Y64A/Y80A/H105A/R106A/Y129A/Y136A/C174A were transfected into 
Δhem1 (6D) using the lithium acetate method.  Spotting of cultures was performed as 




2% glucose SC(-Ura) plates supplemented with 250 µM ALA.  Five to seven colonies 
were picked and inoculated into 2% raffinose SC(-Ura) supplemented with 250 µM ALA 
and grown for 24 h at 30°C to deplete glucose and expand the culture.  The glucose 
depleted culture was subcultured in 2% raffinose SC(-Ura) and grown O/N to deplete 
heme.  Prior to spotting, cultures were resuspended in water to OD600 of 0.2 and ten-fold 
serial dilutions were performed.  10 ul of each dilution was spotted onto a 2% raffinose 
SC(-Ura) plate supplemented with either 0.4% glucose plus 250 µM ALA (positive 
control) or 0.4% galactose plus varying concentrations of hemin (no hemin added as 
negative control).  Plates were incubated at 30°C and imaged every day for five days. 
 
Immunoblotting – For yeast protein extractions, the cells were resuspended in breaking 
buffer (100 mM Tris-HCl pH 8, 1 mM dithiothreitol (DTT), 20 % glycerol) with 1X 
cOmplete protease inhibitor cocktail (Roche Cat. # 04693159001) and equal volume of 
0.5 mm glass beads (Sigma Cat. # G8772).  The cells were disrupted using a bead beater 
for 1 min, 3 times at 4°C.  Cell lysates were collected and protein concentration measured 
using Bradford reagent (BioRad; Cat. # 500-0006).  Equal amounts of protein were run 
on a 12% SDS-PAGE gel and then transferred to a nitrocellulose membrane (BioRad; 
Cat. #162-0115).  Membranes were blocked with 5% milk, incubated with mouse anti-
HA (Covance; Cat. # MMS-101P) at a 1:2,000 dilution for 2 h at room temperature, 
followed by HRP-conjugated donkey anti-mouse IgG (Jackson ImmunoResearch Labs; 
Cat. # 715-035-151) at a 1:10,000 dilution for 1 h at room temperature.  Membranes were 




For L. amazonensis protein extracts, cells were lysed in Thorner buffer and lysates 
were cleared by centrifugation at 15,000 rpm, 15 min, at 4°C.  Total protein was 
quantified using a Pierce Modified Lowry Protein Assay Kit (ThermoScientific; Cat. # 
23240) and equal amounts of protein were run on a 12% SDS-PAGE gel.  Proteins were 
transferred to a nitrocellulose membrane (BioRad; Cat. #162-0115), blocked with 5% 
milk, and probed with mouse anti-HA (Covance; Cat. # MMS-101P) at 1:1,000 dilution 
for 2 h at room temperature followed by HRP-conjugated goat anti-mouse (BioRad; Cat. 
# 170-5047) at 1:20,000 dilution for 1 h at room temperature.  Membranes were 
developed and imaged as described above. 
 
β-Galactosidase Reporter Assay – pYES-DEST52-LHR1-HA was constructed as 
described elsewhere (35).  pRS314m-CYC1-LacZ was constructed as described 
elsewhere (62).  This assay was performed as described previously (35,62).  Briefly, the 
plasmids for expression of LHR1 wild type or mutant proteins (pYES-DEST52-LHR1-
HA or mutants) was co-transformed with the β-galactosidase reporter construct 
(pRS314m-CYC1-LacZ) into Δhem1 (6D) strain using the lithium acetate method and 
transformants were selected on 2% glucose SC(-Ura-Trp) supplemented with 250 µM 
ALA.  Five to seven colonies were picked from the selection plates and inoculated into 
2% raffinose SC(-Ura-Trp) supplemented with 250 µM ALA and grown for 24 h at 30°C 
to deplete glucose and expand the culture.  The glucose depleted culture was subcultured 
in 2% raffinose SC(-Ura-Trp) and incubated O/N at 30°C to deplete heme.  Heme 
depleted cultures were then used to inoculate 2% raffinose SC(-Ura-Trp) supplemented 




varying concentrations of hemin (no hemin added for negative control) at an OD600 of 0.1 
and incubated at 30°C, 250 rpm for 20 h.  Cultures were then evaluated with the β-
galactosidase assay as described elsewhere (181).  β-galactosidase activities were 
normalized to protein concentration for direct comparison. 
 
Leishmania Expression Plasmids – Cloning of LHR1-HA WT/Y18A/H36A/Y80A/ 
Y129A into Leishmania expression vector pXG-SAT (courtesy of Dr. S. Beverley, 
Washington University) was done using the In-Fusion HD Cloning System (Clontech; 
Cat. # 639645) following the manufacturer’s instructions.  Briefly pYES-DEST52-LHR1-
HA (WT, Y18A, H36A, Y80A, & Y129A) plasmids were used to amplify the ORF using 
primers designed for In-Fusion Cloning.  The PCR fragment was then sub-cloned into 
pXG-SAT that had been linearized by BamHI digestion using the In-Fusion system. 






Leishmania Transfections – pXGSAT-LHR1-HA WT/Y18A/H36A/Y80A/Y129A were 
transfected into L. amazonensis Δlhr1/LHR1 as previously described (182).  Parasites 
resistant to 50 µg/ml nourseothricin were selected and screened for expression using 
immunoblotting. 
 
Leishmania Growth Curves – L. amazonensis Δlhr1/LHR1 (SKO), Δlhr1/LHR1 + LHR1, 




Y80A,and Δlhr1/LHR1 + LHR1-Y129A were seeded at 2x105 parasites/ml in PGM and 
growth was monitored by counting using a hemocytometer over a 96h time period. 
 
Macrophage Infections - C57BL/6 mouse bone marrow macrophages (BMM) were 
obtained as previously described (183).  Approximately 1x106 BMM were plated on glass 
coverslips that had been placed in a 6-well plate using RPMI medium (Invitrogen/Gibco; 
Cat. # 11875-119) supplemented with 20% endotoxin-free FBS, 1% 
penicillin/streptomycin, 2 mM L-glutamine, 50 ng/ml human recombinant human 
macrophage colony-stimulating factor (M-CSF) (PeproTech; Cat. # 300-25) and 
incubated for 24 h at 37°C, 5% CO2.  BMMs were infected using axenic amastigotes at a 
ratio of 2 parasites per BMM for 4 h at 34°C.  The cells were washed 3 times with PBS 
and incubated for 1, 36, and 72 h at 34°C.  Coverslips were then fixed in 4% 
paraformaldehyde and permeabilized with 0.1% Triton X-100 for 10 min.  BMM and 
Leishmania DNA were stained with 10 mg/ml DAPI (4’,6-diamidino-2-phenylindole) for 
1 h, then coverslips washed with PBS and mounted using ProLong Gold Antifade 
Mountant (LifeTechnologies; Cat. # P36934).  The number of intracellular parasites was 
determined by counting the total macrophages and the total intracellular parasites per 
microscopic field using a Nikon E200 epifluorescence microscope.  Counts were 
performed in triplicate for each period of infection.  The number of amastigotes was 
divided by the number of macrophages and multiplied by 100 to obtain number of 





Immunofluorescence – Infected BMM were fixed with 4% paraformaldehyde, quenched 
with 15 mM NH4Cl, and permeabilized with 0.1% Triton X-100.  Coverslips were 
washed with PBS and blocked with 3% Bovine Serum Albumin (BSA).  For parasite 
staining, coverslips were incubated with mouse polyclonal antibodies prepared using L. 
amazonensis axenic amastigotes (2), followed by Alexa Fluor 546 goat anti-mouse IgG 
(H+L) (Molecular Probes; Cat. # A-11003) at 1:1000 dilution.  Coverslips were washed 
with PBS and stained with 10mg/ml DAPI and then mounted with ProLong Gold 
Antifade Mountant (LifeTechnologies; Cat. # P36934).  Images were acquired using a 
Nikon E200 epifluorescence microscope equipped with a Nikon Digital Sight-Fi1 camera 
using a 100X objective.  Images were processed using Volocity software suite 
(PerkinElmer). 
 
Mouse Infections - Six-week-old female C57BL/6 mice (n = 5 per group) were inoculated 
with 1x106 axenic amastigotes of wild-type (Lam), Δlhr1/LHR1 (SKO), Δlhr1/LHR1 + 
LHR1-HA, Δlhr1/LHR1 + LHR1-HA-Y18A, Δlhr1/LHR1 + LHR1-HA-H36A, Δlhr1/LHR1 
+ LHR1-HA-Y80A, Δlhr1/LHR1 + LHR1-HA-Y129A L. amazonensis in the left hind 
footpad in a volume of 50 µl sterile PBS.  Lesion progression was monitored once a week 
by measuring the left and right hind footpads with a caliper (Mitutoyo Corp., Japan). The 
parasite burden recovered from the infected tissue was determined after 10 weeks by 
limiting dilution (184). The Institutional Animal Care and Use Committee at the 
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